From here to where?
ICON plc (iconplc.com) earns a Brand Analyzer score of 84 out of 100, placing it in the Strong Brand tier among Healthcare brands, SaaS brands, Other brands. Among 2305 Healthcare brands analyzed, ICON plc ranks in the 99th percentile (category average 68, leader 95). The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark. Dimension scores: Name Quality 85/100, Digital Presence 100/100, Visual Identity 93/100, Messaging Clarity 90/100, Trust Foundation 98/100, AI Discoverability 48/100, Brand Authority 65/100.
ICON plc is an Irish pharmaceutical services company founded in 1990 and headquartered in Ireland. It operates as a global clinical research organisation (CRO), providing outsourced clinical research, consulting, and commercialisation services to pharmaceutical, biotechnology, and medical device companies. ICON supports drug and device development from early-phase research through post-marketing commercialisation, combining therapeutic expertise and technology solutions to help clients reduce time to market and improve R&D return on investment.
| Brand Name | ICON plc |
|---|---|
| Domain | iconplc.com |
| Industry | Healthcare, SaaS |
| Founded | 1990 |
| Headquarters | Ireland |
| Main Competitors | IQVIA, Parexel, Syneos Health, Labcorp Drug Development (Covance) (84/100), PPD (Thermo Fisher Scientific), Charles River Laboratories |
Moz Domain Authority 57/100 vs category average 29 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #55,836 on the Tranco list of most-visited sites - strong traffic reinforces the brand's prominence to AI models.
ICON plc has a dedicated Wikipedia entity - a top-weighted signal AI models rely on to identify and describe the brand.
The homepage meta description reads "ICON is the world" (Meta description too short (4 words). No OG description (falling back to meta)) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: og:title, og:type, canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Social footprint: verified profiles on LinkedIn, X (Twitter), Instagram, YouTube, GitHub; no detected presence on Facebook - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
ICON plc scores 58/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
ICON plc has a limited AI-visibility profile at 58/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is visibility (73/100) and its weakest is trust (29/100). It benefits from a recognised Wikipedia company entity, a Wikidata knowledge-graph entry and a global traffic rank of #55,836 (Tranco). The main gaps holding it back: thin schema.org structured data and no llms.txt to steer AI to its best pages.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
ICON plc's main competitors include IQVIA, Parexel, Syneos Health, Labcorp Drug Development (Covance) (84/100), PPD (Thermo Fisher Scientific). These companies compete in the Healthcare space for similar customers, offering comparable products or services.
Sources: ICON plc official site
ICON plc and Labcorp Drug Development (Covance) are competitors in Healthcare. Brand Analyzer scores ICON plc at 84/100 and Labcorp Drug Development (Covance) at 84/100. They target overlapping audiences; the right choice depends on your specific needs and priorities.
Sources: ICON plc official site
Popular alternatives to ICON plc include IQVIA, Parexel, Syneos Health, Labcorp Drug Development (Covance) (84/100), PPD (Thermo Fisher Scientific). Each is an established option in the Healthcare space; the best fit depends on your specific needs, budget, and required features.
Sources: ICON plc official site
ICON plc has moderate AI-search visibility, scoring 58/100 on Brand Analyzer's AI visibility composite (visibility 73, trust 29, recommendation 67). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: ICON plc official site
ICON plc was founded in 1990. ICON plc operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
ICON plc is headquartered in Ireland. ICON plc operates in the Healthcare category.
Sources: Wikidata
ICON plc scores 67/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority; a Wikipedia presence helps.
Sources: ICON plc official site
ICON plc offers outsourced clinical research and development services, including clinical trial management, consulting, and commercialisation support, spanning early-phase research through post-marketing activities for drugs and medical devices.
Sources: ICON plc official site
ICON plc is an Irish pharmaceutical company that operates as a global clinical research organisation (CRO). Founded in 1990 and headquartered in Ireland, it provides outsourced clinical research and development services to pharmaceutical, biotechnology, and medical device companies.
Sources: ICON plc official site
ICON plc provides outsourced clinical research, consulting, and commercialisation services to pharmaceutical, biotechnology, and medical device companies. It supports the full continuum of drug and device development, from early-phase clinical research through to post-marketing commercialisation, using therapeutic expertise and technology solutions to help clients reduce time to market and improve R&D outcomes.
Sources: ICON plc official site
ICON plc can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: ICON plc official site
ICON plc's services are used by pharmaceutical, biotechnology, and medical device companies that require outsourced clinical development, consulting, and commercialisation support.
Sources: ICON plc official site
ICON plc is known for being a leading global clinical research organisation (CRO) that helps pharmaceutical, biotechnology, and medical device companies accelerate the development of drugs and devices through outsourced clinical trial and consulting services.
Sources: ICON plc official site
Ranked closest to ICON plc: Doximity (84/100), Dexcom (84/100), Labcorp (84/100), Eli Lilly and Company (84/100).
A step up - brands to learn from: Abbott (91/100), Wolters Kluwer (92/100).
Category leader: Dassault Systèmes (95/100).